{"id":195181,"date":"2026-08-11T09:36:32","date_gmt":"2026-08-11T04:06:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=195181"},"modified":"2026-08-11T09:36:33","modified_gmt":"2026-08-11T04:06:33","slug":"sun-pharma-advanced-q1-results-fy27-loss-20-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/","title":{"rendered":"Sun Pharma Advanced Q1 FY27 Results: Revenue Rs 39 Cr, Net Loss Rs 20 Cr and Key Highlights"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Sun Pharma Advanced Q1 FY27 results declared August 10, 2026. Revenue Rs 39 Cr (+314.11% YoY). Net Loss Rs 20 Cr (+59.94% YoY). CMP Rs 207.38 (-2.73%).<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharma Advanced<\/a> Q1 FY27 results were declared on August 10, 2026 on a consolidated basis. Revenue expanded +314.11% YoY to Rs 39 Cr from Rs 9.00 Cr in Q1 FY26. The broader <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> index reflected mixed sentiment during the quarter.<\/p>\n<p>Operating profit stood at Rs -36 Cr (+33.89% YoY). The company reported a net loss of Rs 20 Cr, providing the key financial picture for Sun Pharma Advanced Q1 FY27 results.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=sun-pharma-advance-q1-fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Sun_Pharma_Advanced_Q1_FY27_Financial_Highlights\" title=\"Sun Pharma Advanced Q1 FY27 Financial Highlights\">Sun Pharma Advanced Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Sun_Pharma_Advanced_Q1_FY27_Performance_Analysis\" title=\"Sun Pharma Advanced Q1 FY27 Performance Analysis\">Sun Pharma Advanced Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Key_Business_Factors_in_Sun_Pharma_Advanced_Q1_FY27_Results\" title=\"Key Business Factors in Sun Pharma Advanced Q1 FY27 Results\">Key Business Factors in Sun Pharma Advanced Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Revenue_Expansion_in_Q1_FY27\" title=\"Revenue Expansion in Q1 FY27\">Revenue Expansion in Q1 FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Operating_Margin_Performance\" title=\"Operating Margin Performance\">Operating Margin Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Net_Loss_and_Recovery_Roadmap\" title=\"Net Loss and Recovery Roadmap\">Net Loss and Recovery Roadmap<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#FY27_Outlook_for_Sun_Pharma_Advanced\" title=\"FY27 Outlook for Sun Pharma Advanced\">FY27 Outlook for Sun Pharma Advanced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Sun_Pharma_Advanced_Stock_Performance_After_Q1_FY27_Results\" title=\"Sun Pharma Advanced Stock Performance After Q1 FY27 Results\">Sun Pharma Advanced Stock Performance After Q1 FY27 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Key_Risks_for_Sun_Pharma_Advanced\" title=\"Key Risks for Sun Pharma Advanced\">Key Risks for Sun Pharma Advanced<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Sector-Specific_Risks\" title=\"Sector-Specific Risks\">Sector-Specific Risks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Valuation_and_Earnings_Risk\" title=\"Valuation and Earnings Risk\">Valuation and Earnings Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Operational_and_Financial_Risk\" title=\"Operational and Financial Risk\">Operational and Financial Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Frequently_Asked_Questions_on_Sun_Pharma_Advanced_Q1_FY27_Results\" title=\"Frequently Asked Questions on Sun Pharma Advanced Q1 FY27 Results\">Frequently Asked Questions on Sun Pharma Advanced Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#When_were_Sun_Pharma_Advanced_Q1_FY27_results_declared\" title=\"When were Sun Pharma Advanced Q1 FY27 results declared?\">When were Sun Pharma Advanced Q1 FY27 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#What_was_Sun_Pharma_Advanced_revenue_in_Q1_FY27\" title=\"What was Sun Pharma Advanced revenue in Q1 FY27?\">What was Sun Pharma Advanced revenue in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#What_was_Sun_Pharma_Advanced_PAT_in_Q1_FY27\" title=\"What was Sun Pharma Advanced PAT in Q1 FY27?\">What was Sun Pharma Advanced PAT in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#Did_Sun_Pharma_Advanced_declare_a_dividend_in_Q1_FY27\" title=\"Did Sun Pharma Advanced declare a dividend in Q1 FY27?\">Did Sun Pharma Advanced declare a dividend in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#What_is_the_FY27_outlook_for_Sun_Pharma_Advanced\" title=\"What is the FY27 outlook for Sun Pharma Advanced?\">What is the FY27 outlook for Sun Pharma Advanced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/sun-pharma-advanced-q1-results-fy27-loss-20-crore\/#How_did_Sun_Pharma_Advanced_stock_react_to_Q1_FY27_results\" title=\"How did Sun Pharma Advanced stock react to Q1 FY27 results?\">How did Sun Pharma Advanced stock react to Q1 FY27 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_Advanced_Q1_FY27_Financial_Highlights\"><\/span><strong>Sun Pharma Advanced Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px;\">\n<thead>\n<tr style=\"background: #0A0E1A; color: #fff;\">\n<th style=\"padding: 10px; text-align: left; border: 1px solid #DDD;\">Metric<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">Q1 FY27 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">Q1 FY26 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Sun Pharma Advanced Revenue<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">39<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">9.00<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: green;\">+314.11%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Operating Profit<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">-36<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">-54<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: green;\">+33.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Net Profit (PAT)<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">-20<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">-51<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: green;\">+59.94%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Reporting Basis<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\" colspan=\"3\">Consolidated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_Advanced_Q1_FY27_Performance_Analysis\"><\/span><strong>Sun Pharma Advanced Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Data on This Stock<\/strong><\/a><\/p>\n<p>Sun Pharma Advanced Q1 FY27 results reflect strong fundamentals. Revenue momentum were evident with the top line reaching Rs 39 Cr for the April to June 2026 quarter.<\/p>\n<p>Operating profit expanded +33.89% YoY. Net loss of Rs 20 Cr indicates recovery is still in progress. Investors tracking Sun Pharma Advanced Q1 FY27 results will note these as key FY27 milestones.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Sun_Pharma_Advanced_Q1_FY27_Results\"><\/span><strong>Key Business Factors in Sun Pharma Advanced Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Expansion_in_Q1_FY27\"><\/span><strong>Revenue Expansion in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sun Pharma Advanced Q1 FY27 results show revenue expanding +314.11% YoY to Rs 39 Cr from Rs 9.00 Cr in Q1 FY26. Volume-led growth and market share gains in the Pharmaceuticals segment drove the uptick.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operating_Margin_Performance\"><\/span><strong>Operating Margin Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating profit in Sun Pharma Advanced Q1 FY27 results stood at Rs -36 Cr (+33.89% YoY). Better cost absorption and product mix improvement contributed to the operating performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Net_Loss_and_Recovery_Roadmap\"><\/span><strong>Net Loss and Recovery Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net loss of Rs 20 Cr in Sun Pharma Advanced Q1 FY27 results highlights near-term headwinds. Management is implementing cost optimisation and revenue scaling to return to profitability.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend was declared alongside Sun Pharma Advanced Q1 FY27 results. Earnings are being channelled toward operational reinvestment and working capital.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_for_Sun_Pharma_Advanced\"><\/span><strong>FY27 Outlook for Sun Pharma Advanced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharma Advanced is positioned to sustain growth momentum through FY27, backed by order visibility, operational improvements, and sector tailwinds in the pharmaceuticals space. Investors tracking Sun Pharma Advanced Q1 FY27 results should consult a SEBI-registered financial advisor before making decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_Advanced_Stock_Performance_After_Q1_FY27_Results\"><\/span><strong>Sun Pharma Advanced Stock Performance After Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Sun Pharma Advanced live price and get daily stock recommendations.<\/em><\/p>\n<p>Sun Pharma Advanced shares were trading lower at Rs 207.38 (-2.73%) on August 10, 2026, reflecting investor sentiment on Sun Pharma Advanced Q1 FY27 results and the near-term sector outlook. The CMP of Rs 207.38 on the results date reflects broader sentiment toward the pharmaceuticals space.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Sun_Pharma_Advanced\"><\/span><strong>Key Risks for Sun Pharma Advanced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Sector-Specific_Risks\"><\/span><strong>Sector-Specific Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>USFDA regulatory actions, generic pricing pressure, and API cost inflation remain core risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Risk\"><\/span><strong>Valuation and Earnings Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Valuation risk remains if quarterly growth fails to sustain over the next two to three quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operational_and_Financial_Risk\"><\/span><strong>Operational and Financial Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Subsidiary-level underperformance could drag consolidated PAT lower in subsequent quarters.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharma Advanced Q1 FY27 results highlight near-term challenges with revenue at Rs 39 Cr and a net loss of Rs 20 Cr on a Consolidated basis. Execution of the recovery plan will be the key catalyst to watch in coming quarters.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Sun_Pharma_Advanced_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Sun Pharma Advanced Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Sun_Pharma_Advanced_Q1_FY27_results_declared\"><\/span><strong>When were Sun Pharma Advanced Q1 FY27 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma Advanced Q1 FY27 results were declared on August 10, 2026, covering the April\u2013June 2026 quarter on a Consolidated basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Sun_Pharma_Advanced_revenue_in_Q1_FY27\"><\/span><strong>What was Sun Pharma Advanced revenue in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue in Sun Pharma Advanced Q1 FY27 results was Rs 39 Cr, +314.11% YoY from Rs 9.00 Cr in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Sun_Pharma_Advanced_PAT_in_Q1_FY27\"><\/span><strong>What was Sun Pharma Advanced PAT in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net loss in Sun Pharma Advanced Q1 FY27 results was Rs 20 Cr (+59.94% YoY).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Sun_Pharma_Advanced_declare_a_dividend_in_Q1_FY27\"><\/span><strong>Did Sun Pharma Advanced declare a dividend in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No dividend was announced alongside Sun Pharma Advanced Q1 FY27 results. Refer to official NSE and BSE announcements for future dividend updates.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Sun_Pharma_Advanced\"><\/span><strong>What is the FY27 outlook for Sun Pharma Advanced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Management has guided revenue growth and margin improvement for FY27. Sector demand and execution will be key monitorables.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Sun_Pharma_Advanced_stock_react_to_Q1_FY27_results\"><\/span><strong>How did Sun Pharma Advanced stock react to Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma Advanced shares were lower at Rs 207.38 (-2.73%) on August 10, 2026. Consult a SEBI-registered financial advisor before acting on price movements.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharma Advanced Q1 FY27 results: Revenue Rs 39 Cr (+314.11% YoY), Net Loss Rs 20 Cr (+59.94% YoY). Key highlights, analysis and FY27 outlook.<\/p>\n","protected":false},"author":35,"featured_media":195180,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-195181","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["195180"],"_edit_lock":["1786421196:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["73"],"rank_math_title":["Sun Pharma Advanced Q1 FY27 Results: Revenue, Net Loss &amp; Key High"],"rank_math_description":["Sun Pharma Advanced Q1 FY27 results: Revenue Rs 39 Cr (+314.11% YoY), Net Loss Rs 20 Cr (+59.94% YoY). Key highlights, analysis and FY27 outlook."],"rank_math_focus_keyword":["Sun Pharma Advanced Q1 FY27 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["35624"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/sun-pharma-advanced-q1-results-fy27-loss-20-crore.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=195181"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195181\/revisions"}],"predecessor-version":[{"id":195330,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195181\/revisions\/195330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/195180"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=195181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=195181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=195181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}